Kappa-opioid receptors and relapse-like drinking in long-term ethanol-experienced rats
The DOI matches its Crossref record.
Abstract
Rationale The role of the dynorphin/kappa-opioid receptor system in ethanol reinforcement is unclear. Objective Examination of the effects of the highly selective kappa-opioid receptor agonist CI-977 (enadoline) and of the long-acting selective kappa-opioid receptor antagonist nor-binaltorphimine (nor-BNI) on relapse-like drinking measured by the alcohol deprivation effect (ADE) in long-term ethanol-experienced rats. Methods Rats were either implanted with mini-osmotic pumps delivering 0 or 0.01 mg/kg per h CI-977 or received two injections (12 h apart) of nor-BNI (0 or 5 mg/kg i.p.) before representation of alcohol after 2 weeks of alcohol deprivation in a four-bottle home cage drinking paradigm. In a second experiment, long-term ethanol-experienced rats trained in an operant ethanol self-administration paradigm received either acute CI-977 treatment (0, 0.003-0.1 mg/kg i.p.) or two injections (12 h apart) of nor-BNI (0 or 5 mg/kg i.p.) before a 23-h session. Results Chronic CI-977 potentiated ethanol intake and preference during the ADE. Acute CI-977 dose-dependently reduced total lever pressing activity demonstrating an unspecific sedative effect, except for the lowest dose (0.003 mg/kg), which selectively increased lever pressing for ethanol during basal drinking. Nor-BNI did not affect relapse-like drinking at all. Conclusions Stimulation of kappa-opioid receptors can increase ethanol intake, at least in long-term ethanol-experienced rats. Since kappa-opioid receptor ago…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both systemic and intracerebral k-opioid receptor antagonist administration blocked high compulsivelike drug intake that was associated with extended access to and dependence on alcohol (Hölter et al., 2000;Walker and Koob, 2008).”
From Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development (2021) · cites this paper as Hölter et al., 2000
Citations
Cites
Still being checked.
Cited by
A Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
“…deprivation effect in rats with long-term ethanol experience, but acute injection of a k Neuron 59, July 10, 2008 ª2008 Elsevier Inc. 19 antagonist had no effect, suggesting the possibility that ethanol drinking may be an attempt to overcome the aversive effects of k agonists (Holter et al., 2000).”
Alcoholism: A Systems Approach From Molecular Physiology to Addictive Behavior
Spanagel, R. (2009) · Physiological Reviews · doi:10.1152/physrev.00013.2008 · Cited by 634
Self-citationNeuropharmacology of alcohol addiction
Vengeliene, V, Bilbao, A., Molander, A., & Spanagel, R. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.30 · Cited by 571
Self-citationKoob, G. F. (2011) · Current topics in behavioral neurosciences · doi:10.1007/7854_2011_129 · Cited by 423
The role of the dynorphin–κ opioid system in the reinforcing effects of drugs of abuse
Wee, S., & Koob, G. F. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1825-8 · Cited by 398
Pharmacological evidence for a motivational role of κ-opioid systems in ethanol dependence
Walker, B. M., & Koob, G. F. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301438 · Cited by 392
“The present data are also consistent with previous research which found that nor-BNI did not affect nondependent ethanol self-administration (Doyon et al, 2006) or consumption of ethanol within the context of the alcohol deprivation effect (Holter et al, 2000).”
Dynorphin and the pathophysiology of drug addiction
Shippenberg, T. S., Zapata, A., & Chefer, V. I. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.011 · Cited by 387
“However, total lever pressing also decreased suggesting a non-specific effect (Holter et al., 2000).”
BackgroundResultInfluentialDrug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
Neurocircuitry of alcohol addiction
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-62619-6.00003-3 · Cited by 225
Neurobiology of relapse to alcohol in rats
Lê, A. D., & Shaham, Y. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00200-0 · Cited by 229
Development of κ Opioid Receptor Antagonists
Carroll, F. I., & Carlezon, W. A. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301783x · Cited by 186
The dynorphin/κ-opioid receptor system and its role in psychiatric disorders
Tejeda, H. A., Shippenberg, T. S., & Henriksson, R. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0844-x · Cited by 180
Drugs for relapse prevention of alcoholism: ten years of progress
Spanagel, R., & Kiefer, F. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.12.005 · Cited by 168
Self-citationBart, G. B., Schluger, J. H., Borg, L., Ho, A., Bidlack, J. M., & Kreek, M. J. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300811 · Cited by 163
Vengeliene, V., Bachteler, D., Danysz, W., & Spanagel, R. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.01.002 · Cited by 150
Self-citationSperling, R. E., Gomes, S. M., Sypek, E. I., Carey, A. N., & McLaughlin, J. P. (2010) · Psychopharmacology · doi:10.1007/s00213-010-1844-5 · Cited by 142
Jarjour, S., Bai, L., & Gianoulakis, C. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.00924.x · Cited by 130
Normal-release and controlled-release oxycodone: pharmacokinetics, pharmacodynamics, and controversy
Davis, M. P., Varga, J., Dickerson, D., Walsh, D., LeGrand, S. B., & Lagman, R. L. (2003) · Supportive Care in Cancer · doi:10.1007/s00520-002-0385-9 · Cited by 133
Alcohol Use Disorder: Neurobiology and Therapeutics
Yang, W., Singla, R., Maheshwari, O., Fontaine, C. J., & Gil‐Mohapel, J. (2022) · Biomedicines · doi:10.3390/biomedicines10051192 · Cited by 140
Decreased Oral Self-Administration of Alcohol In ??-Opioid Receptor Knock-Out Mice
Kovacs, K. M., Szakall, I., O???Brien, D., Wang, R., Vinod, K. Y., Saito, M., Simonin, F., Kieffer, B. L., & Vadasz, C. (2005) · Alcoholism: Clinical & Experimental Research · doi:10.1097/01.alc.0000164361.62346.d6 · Cited by 114
Karkhanis (2017) · doi:10.1016/bs.irn.2017.08.001 · Cited by 113
Heyser, C. J., Moc, K., & Koob, G. F. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300175 · Cited by 113
Suppression by baclofen of alcohol deprivation effect in Sardinian alcohol-preferring (sP) rats
Colombo, G., Serra, S., Brunetti, G., Vacca, G., Carai, M. A. M., & Gessa, G. L. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(02)00333-2 · Cited by 111
Long-Evans Rats Acquire Operant Self-Administration of 20% Ethanol Without Sucrose Fading
Simms, J. A., Bito-Onon, J. J., Chatterjee, S., & Bartlett, S. E. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.15 · Cited by 100
Marinelli, P. W., Lam, M., Bai, L., Quirion, R., & Gianoulakis, C. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00112.x · Cited by 98
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxiety
Schank, J. R., Goldstein, A. L., Rowe, K. E., King, C. E., Marusich, J. A., Wiley, J. L., Carroll, F. I., Thorsell, A., & Heilig, M. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00455.x · Cited by 100
Dynorphin is a downstream effector of striatal BDNF regulation of ethanol intake
Logrip, M. L., Janak, P. H., & Ron, D. (2008) · The FASEB Journal · doi:10.1096/fj.07-099135 · Cited by 96
Mitchell, J., Liang, M. T., & Fields, H. L. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0067-7 · Cited by 96
Serra, S., Brunetti, G., Pani, M., Vacca, G., Carai, M. A. M., Gessa, G. L., & Colombo, G. (2002) · European Journal of Pharmacology · doi:10.1016/s0014-2999(02)01594-7 · Cited by 86
Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol
Anderson, R. I., & Becker, H. C. (2017) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.13406 · Cited by 79
Wang, X., Dow-Edwards, D. L., Anderson, V., MINKOFF, H. L., & Hurd, Y. L. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500375 · Cited by 83
The role of kappa opioid receptors in stress‐induced reinstatement of alcohol seeking in rats
Funk, D., Coen, K., & Lê, A. D. (2014) · Brain and Behavior · doi:10.1002/brb3.222 · Cited by 76
Edenberg, H. J., Wang, J., Tian, H., Pochareddy, S., Xuei, X., Wetherill, L., Goate, A., Hinrichs, T., Kuperman, S., Nurnberger, J. I., et al. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn068 · Cited by 74
Vaccarino, A. L., & Kastin, A. J. (2001) · Peptides · doi:10.1016/s0196-9781(01)00566-6 · Cited by 88
Karkhanis, A. N., Huggins, K. N., Rose, J. H., & Jones, S. R. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.07.022 · Cited by 68
Modulation of alcohol and nicotine responses through the endogenous opioid system
Drews, E., & Zimmer, A. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.09.004 · Cited by 71
Berger, A. L., Williams, A. M., McGinnis, M. M., & Walker, B. M. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.229 · Cited by 75
Psilocybin and LSD have no long-lasting effects in an animal model of alcohol relapse
Meinhardt, M. W., Güngör, C., Skorodumov, I., Mertens, L. J., & Spanagel, R. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0694-z · Cited by 65
Self-citationOpioids in the Hypothalamic Paraventricular Nucleus Stimulate Ethanol Intake
Barson, J. R., Carr, A., Soun, J. E., Sobhani, N. C., Rada, P. V., LEIBOWITZ, S. F., & Hoebel, B. G. (2010) · Alcoholism Clinical and Experimental Research · doi:10.1111/j.1530-0277.2009.01084.x · Cited by 66
Moore, C. F., & Lynch, W. J. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.02.014 · Cited by 61
κ-Opioid Receptors in the Central Amygdala Regulate Ethanol Actions at Presynaptic GABAergic Sites
Kang-Park, M.-H., Kieffer, B. L., Roberts, A. J., Siggins, G. R., & Moore, S. D. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.202903 · Cited by 59
Doyon, W. M., Howard, E. C., Shippenberg, T. S., & Gonzales, R. A. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.04.005 · Cited by 53
Kudryavtseva, N. N., Gerrits, M. A. F. M., Avgustinovich, D. F., Tenditnik, M. V., & van Ree, J. M. (2006) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2006.01.002 · Cited by 49
Sparta, D. R., Ferraro III, F. M., Fee, J. R., Knapp, D. J., Breese, G. R., & Thiele, T. E. (2009) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2008.00808.x · Cited by 45
Nielsen, C. K., Simms, J. A., Pierson, H. B., Li, R., Saini, S. K., Ananthan, S., & Bartlett, S. E. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.07.018 · Cited by 50
Koob, G. F., & Vendruscolo, L. F. (2023) · Current topics in behavioral neurosciences · doi:10.1007/7854_2023_424 · Cited by 54
Reinforcing properties of ethanol in neonatal rats: Involvement of the opioid system.
Nizhnikov, M. E., Varlinskaya, E. I., Petrov, E. S., & Spear, N. E. (2006) · Behavioral Neuroscience · doi:10.1037/0735-7044.120.2.267 · Cited by 45
Ripley, T. L., & Stephens, D. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01406.x · Cited by 50
Cosgrove, K., & Carroll, M. E. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.993 · Cited by 44
Ethanol alters the effect of kappa receptor ligands on dopamine release in the nucleus accumbens
Lindholm, S., Rosin, Å., Dahlin, I., Georgieva, J., & Franck, J. (2007) · Physiology & Behavior · doi:10.1016/j.physbeh.2007.05.039 · Cited by 40
Zapata, A., & Shippenberg, T. S. (2006) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.2006.00069.x · Cited by 39
The Kappa‐Opiate Receptor Impacts the Pathophysiology and Behavior of Substance Use
Mysels, D. J., & Sullivan, M. A. (2009) · American Journal on Addictions · doi:10.1080/10550490902925862 · Cited by 38
The Rise and Fall of Kappa-Opioid Receptors in Drug Abuse Research
Banks, M. L. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_268 · Cited by 39
Stress, kappa manipulations, and aversive effects of ethanol in adolescent and adult male rats
Anderson, R. I., Agoglia, A. E., Morales, M., Varlinskaya, E. I., & Spear, L. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.028 · Cited by 35
Kim, K.-S., Kim, H., Baek, I.-S., Lee, K.-W., & Han, P.-L. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2143-x · Cited by 31
Nguyen, J. D., Grant, Y., & Taffe, M. A. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15520 · Cited by 31
The opioid receptors as targets for drug abuse medication
Noble, F., Lenoir, M., & Marie, N. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13190 · Cited by 36
Early role of the κ opioid receptor in ethanol-induced reinforcement
Pautassi, R. M., Nizhnikov, M. E., Acevedo, M. B., & Spear, N. E. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.01.003 · Cited by 27
Fritz, B. M., & Boehm, S. L. (2015) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2015.05.012 · Cited by 26
Role of single prolonged stress in acquisition of alcohol conditioned place preference in rats
Yu, L., Wang, L., Zhao, X., Song, M., & Wang, X. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.004 · Cited by 25
Foroud, T., Ritchotte, A., Spence, J., Liu, L., Lumeng, L., Li, T., & Carr, L. G. (2003) · Psychiatric Genetics · doi:10.1097/00041444-200309000-00004 · Cited by 21
Ontogenetic differences in ethanol's motivational properties during infancy
Nizhnikov, M. E., Pautassi, R. M., Varlinskaya, E. I., Rahmani, P., & Spear, N. E. (2012) · Alcohol · doi:10.1016/j.alcohol.2011.09.026 · Cited by 19
Zhou, Y., & Kreek, M. J. (2018) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.117.245621 · Cited by 19
Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol
Anderson, R. I., Moorman, D. E., & Becker, H. C. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_100 · Cited by 19
The Dynorphin/-Opioid Receptor System at the Interface of Hyperalgesia/Hyperkatifeia and Addiction
Marchette, R. C. N., Vendruscolo, L. F., & Koob, G. F. (2025) · Current Addiction Reports · doi:10.1007/s40429-025-00618-x · Cited by 19
Accumbal μ‐Opioid Receptors Modulate Ethanol Intake in Alcohol‐Preferring Alko Alcohol Rats
Uhari-Väänänen, J. K., Raasmaja, A., Bäckström, P., Oinio, V., Airavaara, M., Piepponen, P. T., & Kiianmaa, K. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13176 · Cited by 14
Zhou, Y., Crowley, R. S., Prisinzano, T. E., & Kreek, M. J. (2018) · Neuroscience Letters · doi:10.1016/j.neulet.2018.02.056 · Cited by 15
Zhou, Y., & Kreek, M. J. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146410 · Cited by 14
Pirino, B. E., Kelley, A. M., Karkhanis, A. N., & Barson, J. R. (2023) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.15078 · Cited by 13
Moore, C. F., Protzuk, O. A., Johnson, B. A., & Lynch, W. J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.11.013 · Cited by 13
Reconocimiento de objetos por color en ratones mus musculus cepa C57BL/6J
Magani, F., Damianich, A., Duaip, G., Rojo, D., Pimentel, J., Trigila, A. P., & Federman, N. (2013) · Revista Argentina de Ciencias del Comportamiento ( RACC ) · doi:10.32348/1852.4206.v5.n3.5561 · Cited by 14
The κ-opioid receptor antagonist JDTic decreases ethanol intake in alcohol-preferring AA rats
Uhari-Väänänen, J. K., Raasmaja, A., Bäckström, P., Oinio, V., Carroll, F. I., Airavaara, M., Kiianmaa, K., & Piepponen, P. T. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4868-x · Cited by 12
Varaschin, R. K., Wazlawik, E., & Morato, G. S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0095-3 · Cited by 12
The selective κ-opioid receptor antagonist JDTic attenuates the alcohol deprivation effect in rats
Uhari-Väänänen, J. K., Eteläinen, T. S., Bäckström, P., Oinio, V., Carroll, F. I., Raasmaja, A., Kiianmaa, K., & Piepponen, P. T. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.10.003 · Cited by 10
Carai, M. A. M., Agabio, R., Addolorato, G., Gessa, G. L., & Colombo, G. (2006) · Birkhäuser-Verlag eBooks · doi:10.1007/3-7643-7305-9_15 · Cited by 8
Zhou, Y., Liang, Y., & Kreek, M. J. (2020) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2020.172954 · Cited by 7
Fouyssac, M., Everitt, B. J., & Belin, D. (2016) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2016.11.018 · Cited by 8
Age as a factor in stress and alcohol interactions: A critical role for the kappa opioid system
Diaz, M. R., Przybysz, K. R., & Rouzer, S. K. (2017) · Alcohol · doi:10.1016/j.alcohol.2017.10.002 · Cited by 8
Zhou, Y., Zhou, D. C., & Kreek, M. J. (2022) · Journal of Pharmaceutics & Pharmacology · doi:10.13188/2327-204x.1000032 · Cited by 11
Vázquez-León, P., Miranda-Páez, A., Sánchez-Castillo, H., & Marichal‐Cancino, B. A. (2023) · Pharmacological Reports · doi:10.1007/s43440-023-00522-z · Cited by 6
Nizhnikov, M. E., Varlinskaya, E. I., & Spear, N. E. (2009) · PubMed · Cited by 5
Neurobiology of negative reinforcement as a driving force in alcohol addiction
Vendruscolo, L. F., & Koob, G. F. (2026) · Neuron · doi:10.1016/j.neuron.2026.04.038 · Cited by 5
Alcohol Withdrawal and Proopiomelanocortin Neuropeptides in an Animal Model of Alcohol Dependence
Müschen, L. H., Rhein, M., Hoppe, V., John, N., Schwabe, K., Frieling, H., Bleich, S., & Muschler, M. A. N. (2019) · Neuropsychobiology · doi:10.1159/000499844 · Cited by 5
Pajser, A., Fisher, H., & Pickens, C. L. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.113212 · Cited by 3
Vázquez-León, P., Arenas-Martínez, U., Córdova-Maqueda, D., Fregoso-Aguilar, T. A., Juan, E. R., & Miranda-Páez, A. (2021) · Acta Neurobiologiae Experimentalis · doi:10.21307/ane-2021-005 · Cited by 3
Frameworks of Alcohol Addiction
Koob, G. F. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-405941-2.00001-8 · Cited by 2
Behavioral and Molecular Aspects of Alcohol Craving and Relapse
Spanagel, R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-343-9_15 · Cited by 3
Self-citationCarsten, K., & Selena, E. (2012) · InTech eBooks · doi:10.5772/32239 · Cited by 1
Шагиахметов, Ф. Ш., Proskuryakova, T. V., & Shamakina, I. Y. (2015) · Neurochemical Journal · doi:10.1134/s1819712415040157 · Cited by 1
Flores‐Ramirez, F. J., Illenberger, J. M., & Martin‐Fardon, R. (2024) · Neurobiology of Stress · doi:10.1016/j.ynstr.2024.100695 · Cited by 1
Cocaine effects on striatal dynorphin and CART neuropeptides : Association to mood disorder
Fagergren, P. (2003) · Figshare · Cited by 1
Cannarsa, R. (2009) · AMS Dottorato Institutional Doctoral Theses Repository (University of Bologna) · doi:10.6092/unibo/amsdottorato/2084
March, S. M., & Miranda‐Morales, R. S. (2009) · Revista Argentina de Ciencias del Comportamiento ( RACC ) · doi:10.32348/1852.4206.v1.n1.5302 · Cited by 4
Freiwilliger Alkoholkonsum bei Nagern: Einfluss von Emotionalität und Stress
Henniger, M. S. H. (2002) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.248
Self-citationMolekulare Grundlagen der Alkoholsucht
Spanagel, R. (2003) · Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz · doi:10.1007/s00103-002-0509-x
Self-citationNeuropeptide Receptors as Treatment Targets in Alcohol Use Disorders
Aziz, A. M. A. (2017) · Linköping University medical dissertations · doi:10.3384/diss.diva-139884
(2021) · Elsevier eBooks · doi:10.1016/b978-0-12-816793-9.00001-3
Holguin, G., & Martin‐Fardon, R. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1729040 · Cited by 1
Шагиахметов, Ф. Ш., Krupitsky, E. M., Shamakina, I. Y., Anokhin, P. K., Arkus, M. L., & Scheidegger, Y. M. (2026) · V M BEKHTEREV REVIEW OF PSYCHIATRY AND MEDICAL PSYCHOLOGY · doi:10.31363/2313-7053-2026-1-1179
Opioid Antagonists for Hedonic Liberation—Not All Is Over
Шагиахметов, Ф. Ш., Shamakina, I. Y., Kokhan, V. S., & Krupitsky, E. M. (2026) · Future Pharmacology · doi:10.3390/futurepharmacol6020026
Metadata
- Authors
- Hölter, S. M., Henniger, M. S. H., Lipkowski, A. W., & Spanagel, R.
- Affiliations
- Max Planck Institute of Psychiatry (DE)
- Venue
- Psychopharmacology
- Published
- 2000-12-12
- Volume
- 153
- Issue
- 1
- Pages
- 93-102
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2066529122
- Cited by
- 100
- References
- 0
- Citations by year
- 2026: 4 · 2025: 1 · 2024: 1 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 5 · 2019: 4 · 2018: 4 · 2017: 4 · 2016: 4 · 2015: 4 · 2014: 3 · 2013: 4 · 2012: 6
- FWCI
- 1.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- kappa opioid receptor, ethanol reinforcement, dynorphin, nor-binaltorphimine, alcohol deprivation effect, ethanol self-administration, aversive effects, sedation
- MeSH terms
- Alcohol Drinking, Animals, Benzofurans, Conditioning, Operant, Drinking, Eating, Male, Naltrexone, Pyrrolidines, Recurrence, Self Administration, Rats, Wistar, Receptors, Opioid, kappa, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.